Tyrosine is sold in supplement form in nearly every gym, pharmacy, and online health retailer in the United States, marketed for focus, cognitive performance, stress resilience, and athletic output. A large-scale study published in Aging-US and receiving widespread coverage on June 15, 2026 raises an unexpected flag: men with higher circulating tyrosine levels may have lifespans nearly a year shorter than those with lower levels.
The finding does not establish causality, and researchers emphasize that it requires further mechanistic investigation before clinical recommendations change. But it adds a notable complication to the uncritical enthusiasm surrounding one of the supplement industry’s most widely used amino acids.
What the Study Found — Design, Methods, and Findings
The paper, “The role of phenylalanine and tyrosine in longevity: a cohort and Mendelian randomization study,” was published in Aging-US in October 2025 and received prominent new ScienceDaily coverage on June 15, 2026. Led by Jie V. Zhao and colleagues from the University of Hong Kong and University of Georgia, the study analyzed health and genetic data from more than 270,000 UK Biobank participants.
The researchers used Mendelian randomization (MR) — a genetic technique that uses naturally occurring genetic variants to estimate causal effects, reducing the confounding that limits observational studies.
Key findings:
- Both phenylalanine and tyrosine showed initial observational associations with higher mortality risk
- After Mendelian randomization, only tyrosine maintained a consistent, potentially causal association
- In men, genetically elevated tyrosine was associated with lifespan reduction of approximately 0.91 years (95% CI: −1.60 to −0.21)
- No significant association in women (−0.36 years, 95% CI: −0.96 to 0.23, not statistically significant)
- Phenylalanine showed no independent association with lifespan after controlling for tyrosine
- The sex-specific effect in men persisted after extensive covariate adjustment
Tyrosine Lifespan Study Key Data
Detail
Published in
Aging-US (October 3, 2025; ScienceDaily coverage June 15, 2026)
Lead authors
Jie V. Zhao, Yitang Sun, Junmeng Zhang, Kaixiong Ye
Institutions
University of Hong Kong; University of Georgia
DOI
10.18632/aging.206326
Participants
270,000+ UK Biobank
Methods
Cohort analysis + Mendelian randomization
Finding in men
Genetically elevated tyrosine: −0.91 years lifespan (95% CI −1.60 to −0.21)
Finding in women
No statistically significant association
Causality established
No — association, not proven causality
Tyrosine’s primary roles
Dopamine, norepinephrine, epinephrine precursor; metabolism regulation
Common in supplements
Pre-workout, nootropics, stress support products
What Tyrosine Is — and Why It’s Everywhere in Supplements
Tyrosine is a conditionally essential amino acid the body synthesizes from phenylalanine. It is naturally abundant in protein-rich foods: meat, fish, eggs, dairy, nuts, soy. Its appeal as a supplement ingredient rests on its role as a precursor to dopamine, norepinephrine, and epinephrine — neurotransmitters that influence mood, motivation, attention, and the stress response. Multiple human studies have shown short-term cognitive benefits under acute stress conditions.
The supplement industry’s enthusiasm is reflected in tyrosine’s presence across a broad array of products: pre-workout formulas (often 1–3 grams per serving), nootropic “brain health” stacks, stress support formulas, and standalone cognitive products (typically 500mg–2,000mg per dose).
What the Finding Means — and What It Doesn’t
The Mendelian randomization approach estimates what would happen if tyrosine levels were genetically elevated from birth — not what happens when a healthy adult supplements for a year. The study cannot determine whether supplementation harms longevity, whether the association reflects a causal mechanism, or whether elevated tyrosine is a marker for some other underlying biological state.
The American Council on Science and Health noted that “elevated tyrosine may possibly be a marker for other biological processes rather than a direct cause” and that “the findings do not show that tyrosine supplements are harmful.”
What the finding does establish is a credible scientific signal that warrants investigation — and raises questions about whether the supplement industry’s casual marketing of high-dose tyrosine as universally beneficial has adequately accounted for uncharacterized long-term risks.
Frequently Asked Questions
What did the tyrosine and lifespan study find?
Analysis of 270,000+ UK Biobank participants found genetically elevated tyrosine levels were associated with a lifespan reduction of approximately 0.91 years in men. No significant association was found in women. Study published in Aging-US, with major ScienceDaily coverage June 15, 2026.
Does this mean tyrosine supplements are dangerous?
Not definitively. The study does not establish causality. The finding relates to genetically elevated levels from birth — not supplementation in healthy adults. Further research is needed before clinical recommendations change.
What is tyrosine and what is it used for?
Tyrosine is an amino acid serving as a precursor to dopamine, norepinephrine, epinephrine, and thyroid hormones. Found naturally in protein-rich foods and widely used in supplements marketed for focus, cognitive performance, stress support, energy, and athletic performance.
Should men stop taking tyrosine supplements?
There is not yet sufficient evidence to recommend stopping supplementation based on this finding alone. Men using high-dose tyrosine regularly — particularly over extended periods — may want to discuss this finding with their healthcare provider.
What further research is needed?
Mechanistic studies to identify biological pathways through which elevated tyrosine might affect lifespan; studies examining dietary tyrosine manipulation over time in humans; and investigation of the sex-specific finding (effect in men but not women).
